SCHEMBL49576

SCHEMBL49576

CCCC[N]c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.38
ALDH1A1 P00352 1/20 0.38
PCSK9 Q8NBP7 1/20 0.38
PTGS2 P35354 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
NOS2 P35228 1/20 0.35
ALPL P05186 1/20 0.35
ALPG P10696 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96272 0.93 LTA4H (0.38) LTA4HALDH1A1PCSK9MEN1KMT2A
SCHEMBL5964912 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL6542019 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL3542927 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL6717183 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL96871 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL6716782 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL1669437 0.91 MEN1 (0.40) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1
SCHEMBL95534 0.85 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2NOS3
SCHEMBL7794055 0.79 SCN5A (0.44) SMN1; SMN2SIGMAR1NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117342910-A Preparation method of monosubstituted cyclopentadiene 江苏南大光电材料股份有限公司 2024-01-05 CN claimed
CN-117143122-A Boron-containing organic compound and organic electroluminescent device prepared from same 江苏三月科技股份有限公司 2023-12-01 CN claimed
CN-116019794-A Application of amino fullerene material in preparation of exosome PD-L1 inhibition drugs 中国科学院化学研究所 2023-04-28 CN claimed
CN-114345339-B Supported binary metal catalyst, preparation method and application thereof 厦门大学 2023-02-21 CN claimed
US-20150368236-A1 2-(PYRIDIN-3-YL)-5-HETARYL-THIAZOLE COMPOUNDS CARRYING AN IMINE OR IMINE-DERIVED SUBSTITUENT FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2015-12-24 US claimed
EP-2938611-A1 2-(PYRIDIN-3-YL)-5-HETARYL-THIAZOLE COMPOUNDS CARRYING AN IMINE OR IMINE-DERIVED SUBSTITUENT FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2015-11-04 EP claimed
WO-2014102244-A1 2-(PYRIDIN-3-YL)-5-HETARYL-THIAZOLE COMPOUNDS CARRYING AN IMINE OR IMINE-DERIVED SUBSTITUENT FOR COMBATING INVERTEBRATE PESTS BASF SE (DE) 2014-07-03 WO claimed
EP-1852420-B1 Indole compounds for treating respiratory disorders ONO PHARMACEUTICAL CO (JP) 2012-10-17 EP claimed
US-7897664-B2 Pneumatic tire THE GOODYEAR TIRE & RUBBER COMPANY (US) 2011-03-01 US claimed
US-20100076126-A1 PNEUMATIC TIRE THE GOODYEAR TIRE & RUBBER COMPANY 2010-03-25 US claimed
US-6500835-B2 FOR PROPHYLAXIS AND THERAPY OF FIBROSIS INVOLVING EXTRACELLULAR MATRIX DYSBOLISM HAVING A CHYMASE INHIBITOR AS AN EFFECTIVE INGREDIENT; SIDE EFFECT REDUCTION SUNTORY LIMITED (JP) 2002-12-31 US claimed
EP-1150979-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-11-07 EP claimed
US-20010031781-A1 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors ILLIG CARL R (US) 2001-10-18 US claimed
US-6291514-B1 Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors 3-DIMENSIONAL PHARMACEUTICALS, INC. 2001-09-18 US claimed
WO-2000047578-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO claimed
EP-0177740-B1 ACYLATED SACCHARINE DERIVATIVES BAYER AG (DE) 1988-09-28 EP claimed
US-4713389-A Fungicidally and bactericidally active acylated saccharin derivatives BAYER AKTIENGESELLSCHAFT (DE) 1987-12-15 US claimed
EP-0177740-A1 Acylated saccharine derivatives BAYER AG (DE) 1986-04-16 EP claimed
EP-0087709-A1 N,N',N\"-triaryl-1,2,3-triaminopropane derivatives, process for their preparation and their use as intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1983-09-07 EP claimed
US-4139530-A CATIONIC DYES BAYER AKTIENGESELLSCHAFT (DE) 1979-02-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368236-A1 2-(PYRIDIN-3-YL)-5-HETARYL-THIAZOLE COMPOUNDS CARRYING AN IMINE OR IMINE-DERIVED SUBSTITUENT FOR COMBATING INVERTEBRATE PESTS PIR, NT5C, NT5M LTA4H 196/4885ALDH1A1 2254/4885PCSK9 2456/4885
US-20010031781-A1 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors SERPINE1, PRSS3, PRSS2 LTA4H 791/4885ALDH1A1 3209/4885PCSK9 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.